Postoperative Cognitive Dysfunction (POCD)

POCD is not postoperative delirium - Keep these separate. Postoperative delirium (POD) is an acute, fluctuating disturbance of attention and consciousness recognized within minutes to days, most often in older patients with comorbidities. POCD is a subtle cognitive deficit detected on formal testing weeks to months out, with consciousness intact. They sit on one continuum - emergence delirium can progress to POD and then to postoperative cognitive decline - and their inflammatory markers correlate, but prevention, detection, and treatment differ. Filing one under the other is the single most common error in this territory.

You cannot diagnose it at the bedside - POCD requires a comprehensive neuropsychological test battery before surgery and again at follow-up. Subjective report or a single test will not do it, and mild cognitive impairment, delirium, dementia, baseline intelligence, depression, anxiety, and pain all confound the result. In the study literature an MMSE of 23 to 24 was the usual minimum baseline for enrollment. If someone tells you a patient "has POCD" without preoperative testing, they are guessing.

Depth of anesthesia is the lever with the most evidence - Bispectral index monitoring was the dominant technique studied, and the AANA integrative review's recommendation is to hold higher BIS levels of 40 to 60 to reduce short-term POCD, with the value concentrated in patients over 60. It is an added departmental cost and is not standard everywhere, which is the practical obstacle rather than the evidence.

Regional does not reliably protect the brain - ISPOCD1 originally implicated general anesthesia, but later work showed a similar incidence with sedation and with regional anesthesia. A prospective cohort comparing general and spinal anesthesia for extracorporeal shock wave lithotripsy, which deliberately excluded central-acting sedatives from the spinal group, found no significant difference in POCD. Do not promise a family that a block will preserve memory.

Biomarkers are not ready for risk stratification - Three prospective studies across aortic aneurysm repair, joint arthroplasty, and mixed major and minor surgery found APOE4 genotype did not predict POCD. Nitric oxide products, CSF amyloid beta-42/tau ratio, diurnal cortisol pattern, and CYP450 genotype have all produced inconsistent or single-subtest findings. None of these belongs in a preoperative risk discussion yet.

Neuroprotective agents remain unproven - Xenon versus propofol produced no significant difference in POCD incidence in the studies reviewed, and no recommendation for xenon as a neuroprotectant can be made. The dexmedetomidine literature is more encouraging for POD than for POCD, where the evidence base is thinner.

Opioid-sparing analgesia cuts both ways - Inadequate pain control is itself a risk factor for neurocognitive dysfunction, but adding opioid analgesics may also contribute. The AGS position is to optimize pain control with nonopioid analgesics first rather than accepting pain as the cost of avoiding opioids.

What to tell the patient and family - This is not a trivial complication. In a Danish cohort of more than 700 noncardiac surgical patients, POCD was linked to increased mortality, leaving the labor market prematurely, and dependency on welfare systems. The 2017 Mayo Clinic Study of Aging found older adults who develop POCD or POD are three times more likely to end up with permanent cognitive impairment or dementia. Impaired cognition after discharge also degrades medication adherence and symptom management, which feeds directly back into readmission.

Postoperative cognitive dysfunction (POCD) is a decline in cognitive performance after anesthesia and surgery - subtle rather than dramatic, spanning concentration, attention, psychomotor speed, visual and verbal learning, memory, and executive function. It is not delirium: consciousness is clear, there is no fluctuating course, and the timescale is weeks to months rather than hours to days.

In older patients the incidence runs as high as 25% at 2 to 10 days after surgery, falling to 10% at 3 months, 5% at 6 months, and 1% at 1 year. Surgical trauma releases proinflammatory cytokines - interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha - that make the blood-brain barrier more permeable, and the aging brain has less volume, fewer dendritic synapses, and less cognitive reserve to absorb the insult. POCD still has no universally accepted definition, which is why the literature conflicts as much as it does.